Cardiff Oncology Inc (CRDF)

CapEx to Revenue

12.20%

TTM · Retrieved:

CRDF logo

CRDF CapEx to Revenue

Current (TTM)12.20%
CRDF CapEx/Revenue (0.00% → 12.20%)
High-resolution chart · PNG

CRDF capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Cardiff Oncology Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
7.4199%
11.713%
119.2623%
231.0881%
57.1031%
57.6503%
27.7969%
1.3492%
19.802%
216.0105%
715.9955%
129.7464%
250.4509%
60.0178%
0.5929%
10.4444%
1.5385%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.